ICD-10-CM Code C50.0

Malignant neoplasm of nipple and areola

Version 2020 Non-Billable Code Neoplasm Malignant Primary

Not Valid for Submission

C50.0 is a "header" nonspecific and non-billable code code, consider using a code with a higher level of specificity for a diagnosis of malignant neoplasm of nipple and areola. The code is NOT valid for the year 2020 for the submission of HIPAA-covered transactions.

The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: areola or breast (connective tissue) (glandular tissue) (soft parts) areola or breast (connective tissue) (glandular tissue) (soft parts) nipple or nipple .

ICD-10:C50.0
Short Description:Malignant neoplasm of nipple and areola
Long Description:Malignant neoplasm of nipple and areola

Consider the following ICD-10 codes with a higher level of specificity:

Code Classification

  • Neoplasms (C00–D48)
    • Malignant neoplasms of breast (C50)
      • Malignant neoplasm of breast (C50)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020

Table of Neoplasms

The code C50.0 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»areola
C50.0C79.81D05.D24.D48.6D49.3
»breast (connective tissue) (glandular tissue) (soft parts)
  »areola
C50.0C79.81D05.D24.D48.6D49.3
»breast (connective tissue) (glandular tissue) (soft parts)
  »nipple
C50.0C79.81D05.D24.D48.6D49.3
»nipple
C50.0C79.81D05.D24.

Information for Patients


Breast Cancer

Breast cancer affects one in eight women during their lives. No one knows why some women get breast cancer, but there are many risk factors. Risks that you cannot change include

  • Age - the risk rises as you get older
  • Genes - two genes, BRCA1 and BRCA2, greatly increase the risk. Women who have family members with breast or ovarian cancer may wish to be tested for the genes.
  • Personal factors - beginning periods before age 12 or going through menopause after age 55

Other risks include obesity, using hormone replacement therapy (also called menopausal hormone therapy), taking birth control pills, drinking alcohol, not having children or having your first child after age 35, and having dense breasts.

Symptoms of breast cancer may include a lump in the breast, a change in size or shape of the breast, and discharge from a nipple. Breast self-exams and mammography can help find breast cancer early, when it is most treatable. One possible treatment is surgery. It could be a lumpectomy or a mastectomy. Other treatments include radiation therapy, chemotherapy, hormone therapy, and targeted therapy. Targeted therapy uses substances that attack cancer cells without harming normal cells.

Men can have breast cancer, too, but it is rare.

NIH: National Cancer Institute


[Learn More]